Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: Final report of a Phase I/II study

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 765-772

  Siker, Malika L ^a   Firat, Selim Y ^a   Mueller, Wade ^a   Krouwer, Hendrikus ^a   Schultz, Christopher J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Glioblastoma; Low dose rate radiotherapy; Recurrent gliomas; Reirradiation; Resection

Indexed keywords

GLIOBLASTOMAS; LOW DOSE RATE; RECURRENT GLIOMAS; REIRRADIATION; RESECTION;

COBALT; POLYMETHYL METHACRYLATES; TOXICITY; TUMORS;

PATIENT TREATMENT;

COBALT 60;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; GLIOMA; HUMAN; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SEMICONTINUOUS LOW DOSE RATE TELETHERAPY; SURVIVAL RATE; TELETHERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; BRAIN NEOPLASMS; COBALT RADIOISOTOPES; EPENDYMOMA; FEASIBILITY STUDIES; GLIOMA; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SALVAGE THERAPY; YOUNG ADULT;

EID: 84855841206     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.057     Document Type: Article

References (48)

1. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
2. F.G. Barker 2nd, S.M. Chang, and P.H. Gutin Survival and functional status after resection of recurrent glioblastoma multiforme Neurosurgery 42 1998 709 720 discussion 720-703
3. N.A. Vick, I.S. Ciric, and T.W. Eller Reoperation for malignant astrocytoma Neurology 39 1989 430 432
4. GRt Harsh, V.A. Levin, and P.H. Gutin Reoperation for recurrent glioblastoma and anaplastic astrocytoma Neurosurgery 21 1987 615 621
5. A.D. Norden, G.S. Young, and K. Setayesh Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence Neurology 70 2008 779 787
6. K.H. Cho, W.A. Hall, and B.J. Gerbi Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas Int J Radiat Oncol Biol Phys 45 1999 1133 1141
7. S. Sanghavi, R. Skrupsky, and B. Badie Recurrent malignant gliomas treated with radiosurgery J Radiosurg 2 1999 119 125
8. G. Lederman, M. Wronski, and E. Arbit Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel Am J Clin Oncol 23 2000 155 159
9. D. Vordermark, O. Kolbl, and K. Ruprecht Hypofractionated stereotactic re-irradiation: Treatment option in recurrent malignant glioma BMC Cancer 5 2005 55
10. H.K. Kim, A.F. Thornton, and H.S. Greenberg Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy Am J Clin Oncol 20 1997 358 363
11. G.S. Bauman, P.K. Sneed, and W.M. Wara Reirradiation of primary CNS tumors Int J Radiat Oncol Biol Phys 36 1996 433 441
12. T. Veninga, H.A. Langendijk, and B.J. Slotman Reirradiation of primary brain tumours: Survival, clinical response and prognostic factors Radiother Oncol 59 2001 127 137
13. G. Voynov, S. Kaufman, and T. Hong Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy Am J Clin Oncol 25 2002 606 611
14. D. Kondziolka, J.C. Flickinger, and D.J. Bissonette Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms Neurosurgery 41 1997 776 783 discussion 783-775
15. T.A. Chan, J.D. Weingart, and M. Parisi Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy Int J Radiat Oncol Biol Phys 62 2005 1133 1139
16. P.K. Sneed, M.W. McDermott, and P.H. Gutin Interstitial brachytherapy procedures for brain tumors Semin Surg Oncol 13 1997 157 166
17. D.C. Shrieve, E. Alexander 3rd, and P.Y. Wen Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme Neurosurgery 36 1995 275 282 discussion 282-274
18. L.E. Gaspar, L.J. Zamorano, and F. Shamsa Permanent 125iodine implants for recurrent malignant gliomas Int J Radiat Oncol Biol Phys 43 1999 977 982
19. A.J. Gabayan, S.B. Green, and A. Sanan GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis Neurosurgery 58 2006 701 709 discussion 701-709
20. S.B. Tatter, E.G. Shaw, and M.L. Rosenblum An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: Multicenter safety and feasibility trial J Neurosurg 99 2003 297 303
21. S. Patel, J.C. Breneman, and R.E. Warnick Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme Neurosurgery 46 2000 1123 1128 discussion 1128-1130
22. D.A. Larson, J.M. Suplica, and S.M. Chang Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme Neuro Oncol 6 2004 119 126
23. B. Marples, and S.J. Collis Low-dose hyper-radiosensitivity: Past, present, and future Int J Radiat Oncol Biol Phys 70 2008 1310 1318
24. L.A. Marin, C.E. Smith, and M.Y. Langston Response of glioblastoma cell lines to low dose rate irradiation Int J Radiat Oncol Biol Phys 21 1991 397 402
25. C.J. Schultz, and C.R. Geard Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation Int J Radiat Oncol Biol Phys 19 1990 1397 1403
26. C.J. Schultz, D.K. Gaffney, and M.J. Lindstrom Iododeoxyuridine radiosensitization of human glioblastoma cells exposed to acute and chronic gamma irradiation: Mechanistic implications and clinical relevance Cancer J Sci Am 1 1995 151 161
27. B. Marples, B.G. Wouters, and S.J. Collis Low-dose hyper- radiosensitivity: A consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells Radiat Res 161 2004 247 255
28. J.B. Mitchell, J.S. Bedford, and S.M. Bailey Dose-rate effects in plateau-phase cultures of S3 HeLa and V79 cells Radiat Res 79 1979 552 567
29. J.B. Mitchell, J.S. Bedford, and S.M. Bailey Dose-rate effects in mammalian cells in culture III. Comparison of cell killing and cell proliferation during continuous irradiation for six different cell lines Radiat Res 79 1979 537 551
30. S.E. Combs, V. Widmer, and C. Thilmann Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM) Cancer 104 2005 2168 2173
31. R.S. Hudes, B.W. Corn, and M. Werner-Wasik A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma Int J Radiat Oncol Biol Phys 43 1999 293 298
32. S.F. Shepherd, R.W. Laing, and V.P. Cosgrove Hypofractionated stereotactic radiotherapy in the management of recurrent glioma Int J Radiat Oncol Biol Phys 37 1997 393 398
33. S.E. Combs, C. Thilmann, and L. Edler Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution J Clin Oncol 23 2005 8863 8869
34. W.K. Sinclair Cyclic x-ray responses in mammalian cells in vitro Radiat Res 33 1968 620 643
35. B. Marples, B.G. Wouters, and M.C. Joiner An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity: A plausible underlying mechanism? Radiat Res 160 2003 38 45
36. B. Xu, S.T. Kim, and D.S. Lim Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation Mol Cell Biol 22 2002 1049 1059
37. A. Krempler, D. Deckbar, and P.A. Jeggo An imperfect G2M checkpoint contributes to chromosome instability following irradiation of S and G2 phase cells Cell Cycle 6 2007 1682 1686
38. B. Marples, M.C. Joiner, and K.A. Skov The effect of oxygen on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79-379A cells Radiat Res 138 1994 S17 S20
39. Schultz CJ, Davies BM. Confirmation of an inverse dose rate effect associated with a G2M block in two human glioblastoma cell lines. Proceedings of the 41st Annual Meeting of the Radiation Research Society. Dallas, TX; 1993. p. 156.
40. Schultz CJ, Davies BM. G2M block characteristics as a function of dose rate in two human glioblastoma cell lines. Proceedings of the 42nd Annual Meeting of the Radiation Research Society. Nashville, TN; 1994. p. 177.
41. M. Krause, J. Wohlfarth, and B. Georgi Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo Int J Radiat Biol 81 2005 751 758
42. B. Pierquin Curie Medal Lecture 2000. The optimization of delivered dose in radiotherapy: Is it related to low dose rate? Radiother Oncol 58 2001 7 9
43. S. Yamada, Y. Takai, and K. Nemoto Low-dose rate telecobalt therapy as a boost against esophageal carcinomas Cancer 69 1992 1099 1103
44. B. Pierquin, E. Calitchi, and J.J. Mazeron Update on low dose rate irradiation for cancers of the oropharynx: May 1986 Int J Radiat Oncol Biol Phys 13 1987 259 261
45. B. Pierquin, M. Tubiana, and C. Pan Long-term results of breast cancer irradiation treatment with low-dose-rate external irradiation Int J Radiat Oncol Biol Phys 67 2007 117 121
46. G.M. Cannon, W.A. Tome, and H.I. Robins Pulsed reduced dose-rate radiotherapy: case report: A novel re-treatment strategy in the management of recurrent glioblastoma multiforme J Neurooncol 83 2007 307 311
47. W.A. Tomé, and S.P. Howard On the possible increase in local tumour control probability for gliomas exhibiting low dose hyper- radiosensitivity using a pulsed schedule Br J Radiol 80 2007 32 37
48. W.A. Tomé, J. Atkinson, and H.I. Robins Pulsed reduced dose-rate radiotherapy: A novel re-treatment strategy in the management of large volume recurrent glioma Int J Radiat Oncol Biol Phys 69 2007 S241 S242